Cosmecca Korea Co Ltd
Cosmecca Korea Co Ltd is a personal products company that generates revenue primarily through the production and sale of cosmetics and related personal care items.
Business. Cosmecca Korea Co Ltd (241710.KQ) is a South Korean company engaged in the personal products industry, operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
Analyst recommendations
13 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Cosmecca Korea Co Ltd (241710.KQ) is a South Korean company engaged in the personal products industry, operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic revenue breakdowns are not disclosed in the available data.
Cosmecca Korea maintains a debt-to-equity ratio of 0.58, indicating a moderate level of leverage, and a current ratio of 1.41, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's cash and equivalents are negative at -4.87 million KRW, which raises concerns about its liquidity position.
In terms of profitability, the company's return on equity (ROE) is 7.03%, and its return on assets (ROA) is 2.82%. These figures are below the typical thresholds for strong performance in the personal products industry, indicating that the company may not be generating returns as efficiently as its peers.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risks if market conditions in its primary market deteriorate.
Looking at growth, the company's operating cash flow is 28.28 billion KRW, and its free cash flow is 6.90 billion KRW. These figures suggest the company is generating positive cash flows, which could support future growth initiatives. However, the capital expenditure of -22.03 billion KRW indicates a significant outlay on long-term investments.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its ability to meet short-term obligations without additional financing.
Recent investor relations data show a mean price target of 111,100 KRW and a median price target of 120,000 KRW, with a mean recommendation of 1.77, indicating a generally positive outlook from analysts. There are 3 strong-buy and 10 buy recommendations, with no hold recommendations.
- Cosmecca Korea has a moderate debt-to-equity ratio and a current ratio above 1, indicating a stable capital structure.
- The company's ROE and ROA are below typical industry benchmarks, suggesting room for improvement in profitability.
- The company's revenue is concentrated in a single segment, which could increase its exposure to market-specific risks.
- The company is generating positive operating and free cash flows, which could support future growth.
- Analysts have a generally positive outlook, with a mean recommendation of 1.77 and a median price target of 120,000 KRW.
- margin_outlook_rationale: The company's gross profit margin is 24.46%, which is in line with industry norms, but there is potential for improvement through cost optimization.
- rd_outlook_rationale: The company's R&D spending is not explicitly disclosed, but the personal products industry typically requires ongoing investment in product development to maintain competitiveness.
Bull / Bear case
Generated · model-assistedRevenue grew 22.2% year-over-year to KRW 640.9 billion in FY2026, demonstrating strong top-line expansion momentum.
Operating income surged 36.1% to KRW 81.8 billion, significantly outpacing revenue growth and indicating margin expansion.
Analysts project 49.1% upside to a mean price target of KRW 111,100, reflecting strong market confidence.
Net income CAGR of 50.3% over four years underscores robust long-term earnings growth trajectory for the company.
Free cash flow plummeted 50.0% to KRW 10.6 billion, signaling significant deterioration in cash generation capabilities.
Long-term debt increased to KRW 172.0 billion, raising leverage concerns alongside a high credit risk flag.
Debt-to-equity ratio of 0.58 places the company in the bottom quartile of peers, indicating higher financial leverage.
Net income growth slowed to just 6.2% year-over-year, suggesting diminishing returns on recent revenue expansion efforts.
Medium liquidity risk flags potential challenges in meeting short-term obligations despite strong operating income growth.
In focus — financials by report
Revenue KRW 178.46B, +39,0% YoY; Operating income +48,1% YoY.
- ▍Revenue KRW 178.46B, +39,0% YoY
- ▍Operating income +48,1% YoY
- ▍Net income −0,4% YoY
- ▍Free cash flow +210,0% YoY
- ▍Net margin 6.6%
Revenue KRW 182.37B, +44,0% YoY; Operating income +78,6% YoY.
- ▍Revenue KRW 182.37B, +44,0% YoY
- ▍Operating income +78,6% YoY
- ▍Net income +97,5% YoY
- ▍Free cash flow +98,7% YoY
- ▍Net margin 9.2%
Revenue KRW 161.73B, +12,5% YoY; Operating income +29,5% YoY.
- ▍Revenue KRW 161.73B, +12,5% YoY
- ▍Operating income +29,5% YoY
- ▍Net income −32,0% YoY
- ▍Free cash flow −151,8% YoY
- ▍Net margin 5.8%
Revenue KRW 118.37B; Operating income KRW 12.29B.
- ▍Revenue KRW 118.37B
- ▍Operating income KRW 12.29B
- ▍Net margin 6.4%
Revenue KRW 128.34B; Operating income KRW 13.06B.
- ▍Revenue KRW 128.34B
- ▍Operating income KRW 13.06B
- ▍Net margin 9.2%
Revenue KRW 126.63B; Operating income KRW 15.21B.
- ▍Revenue KRW 126.63B
- ▍Operating income KRW 15.21B
- ▍Net margin 6.7%
Revenue KRW 143.77B; Operating income KRW 17.78B.
- ▍Revenue KRW 143.77B
- ▍Operating income KRW 17.78B
- ▍Net margin 9.5%
Revenue KRW 640.93B, +22,2% YoY; Operating income +36,1% YoY.
- ▍Revenue KRW 640.93B, +22,2% YoY
- ▍Operating income +36,1% YoY
- ▍Net income +6,2% YoY
- ▍Free cash flow −50,0% YoY
- ▍Net margin 7.1%
Revenue KRW 524.33B; Operating income KRW 60.10B.
- ▍Revenue KRW 524.33B
- ▍Operating income KRW 60.10B
- ▍Net margin 8.2%
Revenue KRW 399.40B, +0,7% YoY; Operating income −43,7% YoY.
- ▍Revenue KRW 399.40B, +0,7% YoY
- ▍Operating income −43,7% YoY
- ▍Net income −70,2% YoY
- ▍Free cash flow −54,8% YoY
- ▍Net margin 0.7%
Revenue KRW 396.47B; Operating income KRW 18.02B.
- ▍Revenue KRW 396.47B
- ▍Operating income KRW 18.02B
- ▍Net margin 2.2%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 6 333,79 |
| Revenue | —no estimate | —no estimate | 770,3B KRW |
| Operating income | —no estimate | —no estimate | 106,8B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Cosmecca Korea Co Ltd Market data — financials · 2026-05-26
- Cosmecca Korea Co Ltd Market data — analyst estimates · 2026-05-26